We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

162 hedge funds and large institutions have $823M invested in Dynavax Technologies in 2021 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 48 increasing their positions, 50 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

124% more call options, than puts

Call options by funds: $26.3M | Put options by funds: $11.7M

120% more capital invested

Capital invested by funds: $374M → $823M (+$449M)

95% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 20

13% more funds holding

Funds holding: 144162 (+18)

4% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 50

2.31% less ownership

Funds ownership: 76.36%74.05% (-2.3%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
162
Holders Change
+18
Holders Change %
+12.5%
% of All Funds
2.84%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
39
Increased
48
Reduced
50
Closed
20
Calls
$26.3M
Puts
$11.7M
Net Calls
+$14.6M
Net Calls Change
+$14.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$124M +$5.42M +657,923 +6%
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$107M
BlackRock
3
BlackRock
New York
$84.1M +$3.03M +366,990 +4%
State Street
4
State Street
Massachusetts
$69.6M -$31.4M -3,803,532 -35%
CC
5
Chicago Capital
Illinois
$56.9M +$59.8K +7,251 +0.1%
Vanguard Group
6
Vanguard Group
Pennsylvania
$52.3M +$1.73M +209,847 +4%
APM
7
Avidity Partners Management
Texas
$34.4M -$4.12M -500,000 -13%
Goldman Sachs
8
Goldman Sachs
New York
$32.2M +$10.2M +1,239,062 +61%
PHS
9
PFM Health Sciences
California
$29.4M +$443K +53,780 +2%
William Blair & Company
10
William Blair & Company
Illinois
$22.2M +$658K +79,842 +4%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$16.7M +$1.21M +146,187 +9%
RSCM
12
Rock Springs Capital Management
Maryland
$16.3M +$75K +9,100 +0.6%
Northern Trust
13
Northern Trust
Illinois
$11.8M -$538K -65,247 -5%
EDRH
14
Edmond de Rothschild Holding
Switzerland
$9.54M -$4.12M -500,000 -34%
RG
15
Redmile Group
California
$8.68M -$2.75M -334,030 -27%
Millennium Management
16
Millennium Management
New York
$8.17M +$5.99M +727,016 +698%
RPAM
17
Rhenman & Partners Asset Management
Sweden
$7.73M -$1.15M -139,323 -15%
Macquarie Group
18
Macquarie Group
Australia
$7.5M -$7.21K -874 -0.1%
Charles Schwab
19
Charles Schwab
California
$6.89M +$354K +42,916 +7%
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$6.49M -$99.4K -12,058 -2%
Morgan Stanley
21
Morgan Stanley
New York
$6.37M +$1.61M +195,304 +43%
N
22
Nuveen
North Carolina
$4.63M +$626K +75,987 +19%
Zurich Cantonal Bank
23
Zurich Cantonal Bank
Switzerland
$4.56M +$1.7M +206,289 +80%
Victory Capital Management
24
Victory Capital Management
Texas
$4.51M -$353K -42,779 -9%
PAM
25
Panagora Asset Management
Massachusetts
$4.32M -$17.9K -2,169 -0.5%

DVAX Hedge Fund Activity: Q1 2021 in Review

162 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q1 2021, worth a combined $823M — up 120% from $374M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new DVAX positions and 20 closed out — a net gain of 19 holders — while 48 added to existing stakes and 50 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $10.2M. The largest seller was State Street, cutting an estimated $31.4M.

  • 162 institutional investors held Dynavax Technologies (DVAX) as of Q1 2021, up from 144 in Q4 2020.
  • Funds reported $823M of Dynavax Technologies stock for Q1 2021, up 120% quarter-over-quarter.
  • 39 funds opened new Dynavax Technologies positions in Q1 2021 and 20 closed out, a net change of +19 holders.
  • The largest Dynavax Technologies buyer in Q1 2021 was Goldman Sachs, an estimated $10.2M added.
  • The largest Dynavax Technologies seller in Q1 2021 was State Street, an estimated $31.4M sold.

Based on aggregated 13F filings for Q1 2021.